Who
Benjamin Jackson
General Counsel
Company insider
Files Form 4 as: General Counsel, Sera Prognostics; E.V.P., General Counsel, Myriad Genetics.
In numbers
- Trades disclosed
- 52
- Buys
- 1
- Sells
- 21
- Bought
- $9,600
- Sold
- $564K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 25 Sep 2019
- Last trade
- 10 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 11 Sep 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $4,3802,190 at $2.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $4,3802,190 at $2.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $4,3802,179 at $2.01 | filing |
| 11 Jun 2026filed 15 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $4,3802,179 at $2.01 | filing |
| 29 May 2026filed 1 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | $9,2005,000 at $1.84 | filing |
| 29 May 2026filed 1 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | $9,2005,000 at $1.84 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —44,215 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —68,550 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —68,550 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —44,215 at $0.00 | filing |
| 11 Mar 2026filed 12 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $2,0951,027 at $2.04 | filing |
| 11 Mar 2026filed 12 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $2,0951,027 at $2.04 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $6,1133,119 at $1.96 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $6,1133,119 at $1.96 | filing |
| 10 Dec 2025filed 11 Dec 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $2,953892 at $3.31 | filing |
| 10 Nov 2025filed 12 Nov 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $18K7,059 at $2.62 | filing |
| 11 Sep 2025filed 12 Sep 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $2,923934 at $3.13 | filing |
| 8 Aug 2025filed 11 Aug 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $16K6,447 at $2.54 | filing |
| 10 Jun 2025filed 12 Jun 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $1,428965 at $1.48 | filing |
| 30 May 2025filed 12 Jun 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | $4,9253,703 at $1.33 | filing |
News
Reviewing Black Diamond Therapeutics (NASDAQ:BDTX) & Sera Prognostics (NASDAQ:SERA)SERA · tickerreport.com · 22 Oct 2026Head to Head Survey: Immunocore (NASDAQ:IMCR) and Sera Prognostics (NASDAQ:SERA)SERA · dailypolitical.com · 20 Oct 2026Arrowhead Pharmaceuticals (NASDAQ:ARWR) versus Sera Prognostics (NASDAQ:SERA) Head to Head ReviewSERA · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name Benjamin Jackson; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.